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Extrachromosomal forms of human immunodeficiency virus (HIV)-1 can be detected in peripheral blood mononuclear cell (PBMC) from
HIV-infected patients in the absence of detectable viral replication and are thought to be a sign of active but cryptic virus replication. No
information, however, are available on whether these forms are also present in animal models for acquired immunodeficiency syndrome
(AIDS) and on their relation with other methods of detection of virus replication. To this aim, a polymerase chain reaction (PCR) approach
was used to detect and analyze unintegrated circular 2-LTR-containing forms in PBMC of simian human immunodeficiency virus
(SHIV)89.6P infected cynomolgus monkeys with RNA levels ranging between 1.8  106 and less than 50 copies/ml of plasma. 2-LTR forms
were detected in 96.5% of monkeys’ samples above 50 copies/ml of plasma, whereas they were present in 75.8% of monkeys’ samples below
50 copies/ml of plasma. Persistence of unintegrated viral DNA in monkeys with undetectable plasma RNA could indicate either stability in
non-dividing cells or ongoing low levels of viral replication in dividing cells.
D 2004 Elsevier Inc. All rights reserved.Keywords: 2-LTR; E-DNA; SHIV; Unintegrated DNA; Circular forms; Episomal DNA
Introduction copy or a tandem double copy of the long terminal repeatDuring human immunodeficiency virus (HIV) and sim-
ian immunodeficiency virus (SIV) infections, unintegrated
forms of extrachromosomal DNA (E-DNA) readily accu-
mulate in the infected cells or tissues throughout the course
of the disease (reviewed in Cara and Reitz, 1997; De Milito
et al., 2003; Sharkey and Stevenson, 2001). The E-DNA is
constituted of both fully reverse-transcribed linear DNA and
closed circular forms of DNA. Circular E-DNA is consid-
ered a marker of nuclear entry because it is detected only in
the nucleus of the infected cell and, after circularization of
the double-stranded linear DNA, contains either a single0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2004.04.006
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E-mail address: ensoli@iss.it (B. Ensoli).(1-LTR and 2-LTR forms, respectively) (Bukrinsky et al.,
1992). The 1-LTR and 2-LTR circular forms of DNA are
considered terminal products of the reverse transcription
process with a short half-life (Bowerman et al., 1987;
Brown et al., 1989; Bukrinsky et al., 1992; Lobel et al.,
1989; Pauza et al., 1994; Sharkey et al., 2000; Varmus and
Swanstrom, 1984). Because of this instability, E-DNA has
been regarded as a convenient marker for ongoing replica-
tion in vitro and in vivo. In particular, recent work from
several groups has shown the persistence of 2-LTR circular
forms in peripheral blood mononuclear cell (PBMC) of
HIV-infected individuals in the absence of detectable plasma
viremia levels. In some instances, this has been correlated
with residual cryptic viral replication (Brussel et al., 2003;
Cara et al., 2002; Morlese et al., 2003; Nunnari et al., 2002;
Sharkey et al., 2000). Nevertheless, the stability of E-DNA
A. Cara et al. / Virology 324 (2004) 531–539532in nonreplicating cells has not yet been characterized and, as
such, could represent a potential reservoir of persistent E-
DNA during lentiviral infections. In this respect, work from
several groups has shown that E-DNA is longer lived in
non-dividing than in dividing cells (Bushman, 2003; Butler
et al., 2002; Pierson et al., 2002).
The infection models of Macaca fascicularis (cynomol-
gus monkey) and Macaca mulatta (rhesus monkey) with the
SIV or SHIV provide experimental HIV-infection animal
models of acquired immunodeficiency syndrome (AIDS)
and are widely used for the development of HIV vaccine
strategies (Stott and Almond, 1995; Warren, 2002). There-
fore, it is important to evaluate virological parameters
during infection and to compare them with those obtained
from humans during infection with HIV-1.
In SHIV89.6P model of infection, after the initial acute
phase of viral replication, virus may phase out below
detectable levels as determined by a highly sensitive method
capable of detecting as low as 50 copies/ml of blood (Ten
Haaft et al., 1998). However, infected monkeys harbor
reservoirs of replication-competent virus because they spo-
radically experience rebound of replicating virus (Igarashi et
al., 2001). So far, it is unknown whether E-DNA is presentTable 1A
2-LTR circle junction analysis in PBMC from SHIV89.6P-infected monkeys with
Monkeys were infected intravenously with either 10 or 20 MID50 of SHIV89.6P
Presence of E-DNA was confirmed by sequencing (grey boxes) or hybridization.and its molecular status in cynomolgus monkeys after
infection with SHIV89.6P and in the absence of detectable
viral replication. As it had been found in humans, the
presence of E-DNA during covert infection might be indic-
ative of low-level residual viral replication.
To this aim, we have analyzed the presence of 2-LTR
forms of DNA in PBMC of SHIV89.6P-infected cynomol-
gus monkeys with detectable or undetectable levels of
plasma viral RNA using a single-round polymerase chain
reaction (PCR)-based assay. In addition, to evaluate se-
quence variation and viral quasi-species at the 2-LTR
junctions, we analyzed the sequence heterogeneity at the
LTR-LTR junction in this population of nonhuman primate
isolates.Results
Presence of 2-LTR junctions in SHIV89.6P-infected
cynomolgus monkeys in the absence of plasma viremia
Twenty-one SHIV89.6P-infected monkeys with plasma
viral RNA levels ranging between 1.8  106 and less thanplasma viremia levels above 50 copies/ml
and viral E-DNA was analyzed by single-round PCR at the week indicated.
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1B). In particular, plasma viremia levels and the presence of
2-LTR E-DNAwas analyzed multiple times on 17 monkeys,
and only once on 4 monkeys. For analysis purposes, in
Table 1A are shown data on samples with viral load above
50 copies/ml of plasma, whereas in Table 1B are shown data
on samples with viral load below 50 copies/ml of plasma.
The median CD4+ T cell counts for the samples with more
than 50 copies/ml of plasma was 609 cells/mm3 (average 9–
1767 cells/mm3), whereas the median CD4+ T cell counts
for the samples with less than 50 copies/ml of plasma was
926 cells/mm3 (average 260–1933 cells/mm3), and the
mean duration for viral loads at levels below 50 copies/ml
was 31 weeks.
Analysis of the presence of 2-LTR was performed on
DNA extracted from selected PBMC samples starting from
week 4 and up to week 92 from SHIV89.6P infection for the
samples with viral load above 50 copies/ml of plasma (Table
1A) and from week 33 and up to week 92 postinfection forTable 1B
2-LTR circle junction analysis in PBMC from SHIV89.6P-infected monkeys with
Monkeys were infected intravenously with either 10 or 20 MID50 of SHIV89.6P a
Presence of E-DNA was confirmed by sequencing (grey boxes) or hybridization.the samples with viral load below 50 copies/ml of plasma
(Table 1B). In all cases, the LMW-enriched DNA was
extracted from a starting cell count of 2  106 to 5  106
PBMC and single-round PCR analysis was performed with
a primer pair spanning the junction between the two LTR, as
described in Materials and methods (Fig. 1). All PCR
products were validated by either hybridization (data not
shown) or nucleic acid sequence analysis (Fig. 2). As shown
in Tables 1A and 1B, a total of 62 determinations were
performed and 2-LTR E-DNA was detected in 53 out of 62
samples (85.5%) regardless of the plasma viremia status. In
particular, 2-LTR E-DNA was detected in 28 out of 29
monkeys’ PBMC with plasma viremia above 50 copies/ml
(96.5%) (Table 1A) and in 25 out of 33 monkeys’ PBMC
with plasma viremia below 50 copies/ml (75.8%) (Table
1B). Concerning the analysis performed at week 38 on
monkey 61783 in which the 2-LTR E-DNA signal was
absent despite the presence of 1100 RNA Eq/ml of plasma,
one explanation might be that the levels of 2-LTR circlesplasma viremia levels below 50 copies/ml
nd viral E-DNA was analyzed by single-round PCR at the week indicated.
Fig. 1. DNA-PCR assay for SHIV89.6P 2-LTR circles. (A) Schematic diagram of single-round PCR strategy for amplification of the 2-LTR junction of
SHIV89.6P DNA. Primer pair is FORN1/REVN1; the expected PCR product is 361 bp. (B) Sensitivity of the PCR assay and hybridization of the PCR product.
Ten-fold dilution (starting at 105 copies) of a plasmid containing known amounts of the SHIV89.6P 2-LTR junction target sequences were amplified with
primer pair FORN1/REVN1 as described under Materials and methods (left). M, 100-bp ladder. Gel was blotted and hybridized with the 5V-end labeled purified
PCR fragment (right) using standard methodologies (Sambrook et al., 1989).
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PCR. A second explanation might be that the cells in the
peripheral blood are not representative of infected cells
present elsewhere in the body that are actually producing
virus. On the other hand, it cannot be excluded that the 2-
LTR forms were not detected because of sequence variation
at the 2-LTR junctions where either of the PCR primers
would not be able to anneal to the target sequence and carry
out the subsequent amplification.
Sequence analysis of 2-LTR junctions
For sequence analysis, PCR reaction products were gel-
purified and, after insertion into the pCR2.1 vector, multiple
clones from different PCR were examined. A total of 15
time points were sequenced at the 2-LTR junctions and
analysis was performed on 10 different monkeys. In partic-
ular, sequencing was carried out once on five monkeys’
PBMC and twice at different time points on five different
monkeys’ samples (Tables 1A and 1B). With regard to the
PCR samples from monkeys with plasma viremia levels
above 50 copies/ml, sequencing was carried out at two
different time points (weeks 38 and 80) on monkey 61775
(Table 1A, grey boxes). Concerning the PCR samples from
monkeys with plasma viremia levels below 50 copies/ml,Fig. 2. Nucleotide sequences at the 2-LTR circle junction derived from PBMC D
corresponding U5-U3 2-LTR junction from the SHIV89.6P genomic sequence (Ka
(Bethesda, MD, USA). Dashes represent gaps introduced in the figure for align
Nucleotides in lower case are those derived from the tRNA primer binding site osequencing was carried out at two different time points on
four different monkeys (monkeys 61754, 61766, 61776, and
61785), whereas at a single time point on five monkeys’
PBMC (monkeys 12, 55123, 61636, 61640, and 61783)
(Table 1B, grey boxes). As shown in Fig. 2, next to the
sequence corresponding to the joining of the unprocessed
two LTR termini derived from the SHIV89.6P predicted
circle junction (top of Fig. 2), we found a high number of
miscellaneous sequences at the junction between the two
LTR. For uniformity, we have decided to employ the
classification used by Randolph and Champoux (1993), in
which the sequences between the two LTR were divided
into various classes (I–V) based on the most likely origin,
features, and preponderance.
Class I junction sequences correspond to the expected
sequence, representing the joining of the unprocessed two
LTR termini. This might indicate the presence of an ineffec-
tive integrase (IN) protein in the infecting provirus. This
class of sequences was found with a frequency of 18 out of
56 PCR clones (32%) in 10 out of 15 monkeys’ samples that
were analyzed (Fig. 2 and Table 2). Furthermore, class I
junction sequences were found at both time points analyzed,
weeks 34 and 71, in monkey 61785 (Fig. 2 and Table 1B).
Class II junction sequences is the very likely conse-
quence of the incomplete removal of the tRNA primerNA of SHIV89.6P-infected monkeys. The sequences were aligned to the
rlsson et al., 1997) using the VNTI suite 6.0 AlignX program from InforMax
ment purposes. Shown in bold are the invariant CA and TG nucleotides.
r from the PPT next to the U3.
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Table 2
Summarized results of the 2-LTR junction fragments obtained after DNA-
PCR and nucleotide sequence analysis






I 18/56 (32%) 10 both ends unprocessed
(ineffective integrase)
II 13/56 (23%) 7 incomplete removal of
tRNA primer
III 12/56 (21.5%) 6 aberrant initiation of
plus-strand synthesis
IV 5/56 (9%) 5 partially processed
for integration
V 8/56 (14.5%) 4 complex deletions
(nonspecific Dnase
activity)
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primer generates junction sequences of different length with
the majority having an extra T at the U5 termini of the
sequence in the right LTR. This class of sequences was
found with a frequency of 13 out of 56 PCR clones (23%) in
7 out of 15 sequenced monkeys’ samples (Fig. 2 and Table
2). Furthermore, class II junction sequences were found at
both time points analyzed in monkeys 61766 (weeks 38 and
61) and 61776 (weeks 61 and 80) (Fig. 2 and Table 1B).
Class III junction sequences contain an anomalous se-
quence in the left U3-LTR termini, which very likely arose
from an aberrant plus-strand DNA synthesis. In fact, all the
clones maintained the conserved TG residues, and the plus-
strand synthesis after the first jump most probably initiated
within the polypurine tract (PPT) leaving from 1 to 17
nucleotides, in addition to the canonical AC nucleotides,
for IN removal before integration (Fig. 2). Conversely, it
might be possible that the sequences derive from a partial
digestion of the PPT primer by the RNase H during reverse
transcription. As such, the subsequent steps of reverse tran-
scription would carry the additional sequence in the reverse-
transcribed viral genome. This class of sequences was found
with a frequency of 12 out of 56 PCR clones (21.5%) in 6 out
of 15 sequenced monkeys’ samples (Fig. 2 and Table 2).
Class IV junction sequences probably derived from
partial processing by IN of either or both the LTR termini,
with consequent failure of integration and 2-LTR circles
formation. This class of sequences was found with a
frequency of 5 out of 56 PCR clones (9%) in 5 out of 15
sequenced monkeys’ samples (Fig. 2 and Table 2). Only one
clone, corresponding to monkey 61754-1 W44, seems to
have been correctly processed at the left U3-LTR termini,
although leaving unprocessed the right U5-LTR termini. All
the other clones possess extra nucleotides at both the left
and right LTR termini, corresponding to unprocessed or
partially processed termini.
Class V junction sequences, containing deletions or
insertions at the junction between the two LTRs, are all ofuncertain origin and, due to their characteristics, are classi-
fied as complex. This class of sequences was found with a
frequency of 8 out of 56 PCR clones (14.5%) in 4 out of 15
sequenced monkeys’ samples (Fig. 2 and Table 2). It is
possible to speculate that nonspecific IN activity or cellular
enzymes like DNases might be responsible for the appear-
ance of these particular E-DNA forms.Discussion
Previous works by others and us on HIV patients have
shown that 50–99% of the patients’ samples with viral
plasma RNA levels below the limits of detection had
detectable 2-LTR circular E-DNA in PBMC (Brussel et
al., 2003; Cara et al., 2002; Morlese et al., 2003; Nunnari et
al., 2002; Sharkey et al., 2000). Patient populations, treat-
ment regimen, PCR conditions, and HIV-1 sequence varia-
tions at the LTR, which would ultimately affect the PCR
conditions, might be responsible for such reported differ-
ences. In the present work, we extended this analysis during
SHIV-89.6P infection of a well-defined population of cyn-
omolgus monkeys, a nonhuman primate model for AIDS,
and found comparable results. Indeed, 75.8% of the samples
with viral plasma RNA levels below 50 copies/ml of plasma
were positive for 2-LTR circles. This form of DNA is found
in the nucleus of the infected cells and it might be indicative
of either ongoing virus replication with the generation of
newly infected cells or with the presence of a reservoir in
which this form remain stable. Consistent with the former
hypothesis, several groups have shown that unintegrated
circular DNA forms are labile in dividing cells and their
half-life does not exceed 48 h. In fact, following in vitro
infection of replicating T-cells, E-DNA rapidly disappears,
thus suggesting that any persistence must be due to active
viral replication (Pauza et al., 1994; Sharkey et al., 2000).
However, in agreement with the latter hypothesis, recent
work has pointed out that in non-dividing cells unintegrated
DNA is stable over a period of several days (Bushman,
2003; Butler et al., 2002; Pierson et al., 2002). Because
unintegrated DNA is unable to replicate due to the absence
of an origin of replication, it is possible that both hypotheses
are correct. As such, newly infected actively replicating T-
cells would dilute and loose the circular form of the virus
while replicating, whereas in non-dividing cells, like termi-
nally differentiated macrophages, non-dividing memory T-
cells or as a yet unidentified cell population, 2-LTR circles
would be maintained for a longer period of time. Neverthe-
less, the presence of 2-LTR forms in monkeys’ samples in
the absence of detectable plasma viremia for 1 year or more
would be indicative of low levels of ongoing viral replica-
tion. Concerning the presence of E-DNA in non-dividing
cells such as macrophages, it should be noted that although
the HIV-1 env present in the SHIV-89.6P derives from a
virus that used both the CCR5 and CXCR4 coreceptors for
entry into monkeys CD4+ T-cells, further passages in
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CXCR4 (Zhang et al., 2000). As such, at least at the early
stages of infection, the virus would replicate exclusively in
CXCR4-bearing cells such as CD4+ T-cells. However, we
have analyzed the presence of E-DNA over an extended
period of time (up to 92 weeks from challenge) and during
this period it cannot be excluded that the virus has reverted
to the dual-tropic background acquiring the ability to infect
macrophages, as described in humans accidentally infected
with HIV-1 (Cornelissen et al., 1995; Moore et al., 2004). In
any case, as for HIV-infected patients, if there were a
population of cells within PBMC where these forms are
more stable, the utility of the assay for monitoring ongoing
SHIV infection would be limited and should be further
explored. In this setting, it would be interesting to determine
whether E-DNA in aviremic animal is more abundant in
certain cell subsets such as resting cells.
A minority of monkeys’ samples did not have detectable
2-LTR forms and, with one exception (monkey 61783, week
38), these samples had no detectable plasma RNA as well.
Moreover, E-DNA-negative samples were those farther
away from the day of SHIV infection. This seems convinc-
ing for monkeys 55129, 61754, 61783, and 61785 although
with one exception (monkey 12), in which the presence of 2-
LTR junctions could represent a reactivation of viral repli-
cation after a period of absence of detectable viral replica-
tion. Although it is possible that the absence of 2-LTR forms
may merely represent a sampling error due to the starting
cell number, this would also reflect the viral status in the
infected monkeys. In fact, the longer infected monkeys
remained with plasma viremia below detection, the higher
was the likelihood that 2-LTR circles were undetectable.
Sequence analysis at the junction between the two LTR
indicated that miscellaneous sequences were present in the
monkeys’ samples. Very likely, all the junctions resulted
from ligation of integration-defective viral DNA ends. Of
the 15 samples analyzed, 13 contained more than one class
of sequence at the time of analysis. This would suggest that
multiple forms of circular 2-LTR co-existed in the PBMC
populations. Moreover, although 18 out of 56 class I
junction sequences contained the predicted circular junction
GAT#AC, the majority (38/56) showed heterogeneous inser-
tions or deletions. These classes of junctions (II–V) do not
result from the joining of normal unprocessed LTR termini
but most likely from errors incorporated during the reverse
transcription process. These various LTR termini sequences
lack the conserved residues that act as substrates for
integration and, therefore, end up as substrates for the
formation of closed circular DNA. On the other hand, a
poorly active IN might account for the formation of class IV
junction sequences, in which the LTR termini have been
partially processed for integration. Similar studies involving
HIV-1 infection in vivo also showed some sequence het-
erogeneity at the 2-LTR circle junctions (Cara and Reitz,
1997; Jurriaans et al., 1992; Sharkey et al., 2000). However,
in these studies on HIV-1, the analysis was performed on alimited number of patients and PCR-derived clones. Overall,
the sequence data derived from our monkey population
displayed sequence heterogeneity across the 2-LTR junction
with the majority of clones lacking the normal unprocessed
ends for ligation as seen in vivo with HIV infection and in
vitro with SIV and HIV infections (Buckman et al., 2003;
Cara et al., 2002; Randolph and Champoux, 1993; Sharkey
et al., 2000). Unfortunately, this junction sequence hetero-
geneity precludes the use of a junctional probe to selectively
detect the presence of 2-LTR circular DNA in infected
monkeys.
Larger studies with long-term follow-up will be needed
to determine if the absence of 2-LTR DNA in PBMC of
SIV/SHIV-infected monkeys predicts a better outcome, for
example, after challenge, during a vaccination protocol.
Moreover, longitudinal in vivo and in vitro studies are
required to address whether these circular forms are stable
in different cell types, and to determine if the presence or
absence of unintegrated DNA might be prognostic of the
duration of inhibition of viral replication.Materials and methods
Animals and samples collection
Twenty-one adult male cynomolgus monkeys (M. fasci-
cularis) were housed in single cages within level-three
biosafety facilities according to the European guidelines
for nonhuman primate care (EEC, Directive No. 86-609,
November 24, 1986). All animals were infected intrave-
nously with either 10 or 20 MID50 of the SHIV89.6P virus.
Clinical observation, weight measurements, and bleeding
for hematological and virological analysis were taken while
under Ketamine Hydrocloride anesthesia (10 mg/kg, im).
Bleedings were performed by collection of 10 ml of whole
blood in an acid citrate-containing tube.
Plasma SHIV RNA levels
For RNA analysis, plasma was separated by centrifuga-
tion and viral RNA levels were determined utilizing an
ultrasensitive QC-RNA-PCR with a lower limit of detection
of 50 copies/ml of plasma as already described (Ten Haaft et
al., 1998).
2-LTR detection
For E-DNA analysis, PBMC were isolated from blood
samples using Ficoll–Hypaque gradient centrifugation.
After separation, PBMC were pelleted by centrifugation
into 2  106 to 5  106 aliquots and cell pellets were kept
frozen at 80 jC until analysis. To enrich for unintegrated
E-DNA, low-molecular-weight (LMW) DNA was extracted
from the cell pellet using the QIAprep Spin miniprep kit
from QIAGEN (Valencia, CA) as described (Cara et al.,
A. Cara et al. / Virology 324 (2004) 531–5395382002). A single-round DNA-PCR reaction was performed
to detect the 2-LTR forms of E-DNA using the primer pair
FORN1/REVN1, amplifying a fragment of DNA of
expected 361 bp encompassing the 2-LTR junction be-
tween the 3V and 5V LTR, respectively (Fig. 1). The PCR
parameters were as follows: one step of denaturation for 5
min at 94 jC followed by 94 jC, 30 s; 60 jC, 30 s; and
72 jC, 30 s, for 40 cycles with a final elongation step of
10 min at 72 jC, using 10 pmol of each primer: FORN1:
5V-GTG ACT CCA CGC TTG TTT GC-3V, corresponding
to nt 10320–10339 in the SHIV89.6P DNA sequence (R
region of the 3V LTR), in the sense orientation; REVN1:
5V-CTC CTG TGC CTC ATC TGA TAC C-3V,
corresponding to nt 157–178 in the SHIV89.6P nucleotide
sequence (U3 region of the 5VLTR), in the antisense
orientation. PCR products were then analyzed by electro-
phoresis on 2% agarose gels. Bands were confirmed by
hybridization using the FORN1/REVN1 PCR product as
probe (Fig. 1 and data not shown) or by nucleic acid
sequence analysis (see below) following standard method-
ologies (Sambrook et al., 1989).
Cloning and sequencing of the PCR products
For cloning, 2-LTR containing PCR products were size-
selected and gel purified using the QIAGEN gel purification
kit (QIAGEN). After purification, 2-LTR containing PCR
products were cloned into the pCR2.1 vector (Invitrogen,
California). After cloning, plasmids were isolated with the
QIAGEN miniprep purification kit (QIAGEN) and digested
with EcoRI to confirm insertion of the PCR products.
Plasmid DNAs were sequenced with T7AS primer using
an ABI/Prism-377 DNA sequencer (Perkin Elmer).Acknowledgments
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